Davis New York Venture Fund returned +17.51% in 2024. The fund has consistently grown wealth for shareholders since its ...

CSL has delivered a solid result for the first half of fiscal year 2025, driven by the strong performance of ... How that comes together has changed slightly based on the performance of the ...

Pharmaceutical company Shield Therapeutics, which has a base in Gateshead, has officially appointed a chief executive.

I believe Shield is poised for significant growth, and I look forward to working alongside our talented team and our partner Viatris Inc., to build on the company’s strong foundation. "Together ...

I believe Shield is poised for significant growth, and I look forward to working alongside our talented team and our partner Viatris Inc., to build on the company’s strong foundation. "Together, we ...

Analysts' consensus rating on Viatris stock is cautious, with a "Hold" overall rating. Out of seven analysts covering the stock, one advises a "Strong Buy," four suggest a "Hold," one recommends ...

As Leo stands in his office, overseeing the entrance of Viatris' bustling office in the Netherlands, he reflects on the 50 years that have shaped his journey with the company. From his early days ...

Startup Together AI, which provides users access to ... to $3.3 billion — a signal that corporate demand for AI is still strong. Saudi Arabia's Prosperity7 Ventures co-led the round, which ...

NORTHAMPTON, MA / ACCESS Newswire / February 19, 2025 / By: James Headen Pfitzer, Senior Director, Global Policy, Corporate Affairs, Viatris and ... businesses to work together to find a solution ...